Whatman Completes The Acquisition Of The Assets Of HemaSure Inc.
Meanwhile, Whatman and HemaSure have been working closely on an improved r\LS blood filter and progress has been made towards a relaunch of the product.
David Smith, Chief Executive of Whatman plc, reiterated his previous comment: "This acquisition is a massive opportunity for Whatman. We will become a serious player in leucocyte filtration where our technology and media expertise will be a significant advantage."
Most read news
Organizations
Get the chemical industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.